English
简体中文
Total: £ 56.28
Published Date: 2025-05-06 | Pages: 105 | Tables: 106 | Medical Care
The global market for Small Molecule Chemical Drug CDMO was valued at US$ 57840 million in the year 2024 and is projected to reach a revised size of US$ 126490 million by 2031, growing at a CAGR of 12.0% during the forecast period.
The development and production of small molecule chemical drugs usually involves many complex steps, and the synthesis and production of small molecule chemical drugs require specialized equipment and technology. CDMO (Contract Development and Manufacturing Organization) is an organization that provides outsourcing services to pharmaceutical companies. It can provide a range of services from drug development to production.
North American market for Small Molecule Chemical Drug CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Small Molecule Chemical Drug CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Small Molecule Chemical Drug CDMO in Clinical Stage Projects is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Small Molecule Chemical Drug CDMO include Haixiang Pharmaceutical, Innovent Biologics, Betta Pharmaceuticals, Jiuzhou Pharmaceutical, Puluo Pharmaceutical, Menohua, Tianyu shares, Aoxiang Pharmaceutical, Hetero, CellMark, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Molecule Chemical Drug CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Chemical Drug CDMO.
The Small Molecule Chemical Drug CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Molecule Chemical Drug CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Chemical Drug CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Haixiang Pharmaceutical
Innovent Biologics
Betta Pharmaceuticals
Jiuzhou Pharmaceutical
Puluo Pharmaceutical
Menohua
Tianyu shares
Aoxiang Pharmaceutical
Hetero
CellMark
R&D Systems
Porton Pharmaceuticals
Kai Laiying
Smart Life
Notai Biotech
Aurobindo Pharma
Lonza Group
Catalent Inc.
Recipharm AB
Jubilant Pharmova Ltd
Patheon Inc. (Thermo Fisher Scientific Inc.)
Boehringer Ingelheim Group
Pfizer CentreSource
Baxter International Inc.
Segment by Type
Human Medicine
Veterinary Medicine
Segment by Application
Clinical Stage Projects
Commercialization Stage Projects
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule Chemical Drug CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Chemical Drug CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Human Medicine
1.2.3 Veterinary Medicine
1.3 Market by Application
1.3.1 Global Small Molecule Chemical Drug CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Stage Projects
1.3.3 Commercialization Stage Projects
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Chemical Drug CDMO Market Perspective (2020-2031)
2.2 Global Small Molecule Chemical Drug CDMO Growth Trends by Region
2.2.1 Global Small Molecule Chemical Drug CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Small Molecule Chemical Drug CDMO Historic Market Size by Region (2020-2025)
2.2.3 Small Molecule Chemical Drug CDMO Forecasted Market Size by Region (2026-2031)
2.3 Small Molecule Chemical Drug CDMO Market Dynamics
2.3.1 Small Molecule Chemical Drug CDMO Industry Trends
2.3.2 Small Molecule Chemical Drug CDMO Market Drivers
2.3.3 Small Molecule Chemical Drug CDMO Market Challenges
2.3.4 Small Molecule Chemical Drug CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Chemical Drug CDMO Players by Revenue
3.1.1 Global Top Small Molecule Chemical Drug CDMO Players by Revenue (2020-2025)
3.1.2 Global Small Molecule Chemical Drug CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Small Molecule Chemical Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Molecule Chemical Drug CDMO Revenue
3.4 Global Small Molecule Chemical Drug CDMO Market Concentration Ratio
3.4.1 Global Small Molecule Chemical Drug CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Chemical Drug CDMO Revenue in 2024
3.5 Global Key Players of Small Molecule Chemical Drug CDMO Head office and Area Served
3.6 Global Key Players of Small Molecule Chemical Drug CDMO, Product and Application
3.7 Global Key Players of Small Molecule Chemical Drug CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Chemical Drug CDMO Breakdown Data by Type
4.1 Global Small Molecule Chemical Drug CDMO Historic Market Size by Type (2020-2025)
4.2 Global Small Molecule Chemical Drug CDMO Forecasted Market Size by Type (2026-2031)
5 Small Molecule Chemical Drug CDMO Breakdown Data by Application
5.1 Global Small Molecule Chemical Drug CDMO Historic Market Size by Application (2020-2025)
5.2 Global Small Molecule Chemical Drug CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Small Molecule Chemical Drug CDMO Market Size (2020-2031)
6.2 North America Small Molecule Chemical Drug CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Small Molecule Chemical Drug CDMO Market Size by Country (2020-2025)
6.4 North America Small Molecule Chemical Drug CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Chemical Drug CDMO Market Size (2020-2031)
7.2 Europe Small Molecule Chemical Drug CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Small Molecule Chemical Drug CDMO Market Size by Country (2020-2025)
7.4 Europe Small Molecule Chemical Drug CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Chemical Drug CDMO Market Size (2020-2031)
8.2 Asia-Pacific Small Molecule Chemical Drug CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Small Molecule Chemical Drug CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Small Molecule Chemical Drug CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule Chemical Drug CDMO Market Size (2020-2031)
9.2 Latin America Small Molecule Chemical Drug CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Small Molecule Chemical Drug CDMO Market Size by Country (2020-2025)
9.4 Latin America Small Molecule Chemical Drug CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Chemical Drug CDMO Market Size (2020-2031)
10.2 Middle East & Africa Small Molecule Chemical Drug CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Small Molecule Chemical Drug CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Small Molecule Chemical Drug CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Haixiang Pharmaceutical
11.1.1 Haixiang Pharmaceutical Company Details
11.1.2 Haixiang Pharmaceutical Business Overview
11.1.3 Haixiang Pharmaceutical Small Molecule Chemical Drug CDMO Introduction
11.1.4 Haixiang Pharmaceutical Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.1.5 Haixiang Pharmaceutical Recent Development
11.2 Innovent Biologics
11.2.1 Innovent Biologics Company Details
11.2.2 Innovent Biologics Business Overview
11.2.3 Innovent Biologics Small Molecule Chemical Drug CDMO Introduction
11.2.4 Innovent Biologics Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.2.5 Innovent Biologics Recent Development
11.3 Betta Pharmaceuticals
11.3.1 Betta Pharmaceuticals Company Details
11.3.2 Betta Pharmaceuticals Business Overview
11.3.3 Betta Pharmaceuticals Small Molecule Chemical Drug CDMO Introduction
11.3.4 Betta Pharmaceuticals Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.3.5 Betta Pharmaceuticals Recent Development
11.4 Jiuzhou Pharmaceutical
11.4.1 Jiuzhou Pharmaceutical Company Details
11.4.2 Jiuzhou Pharmaceutical Business Overview
11.4.3 Jiuzhou Pharmaceutical Small Molecule Chemical Drug CDMO Introduction
11.4.4 Jiuzhou Pharmaceutical Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.4.5 Jiuzhou Pharmaceutical Recent Development
11.5 Puluo Pharmaceutical
11.5.1 Puluo Pharmaceutical Company Details
11.5.2 Puluo Pharmaceutical Business Overview
11.5.3 Puluo Pharmaceutical Small Molecule Chemical Drug CDMO Introduction
11.5.4 Puluo Pharmaceutical Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.5.5 Puluo Pharmaceutical Recent Development
11.6 Menohua
11.6.1 Menohua Company Details
11.6.2 Menohua Business Overview
11.6.3 Menohua Small Molecule Chemical Drug CDMO Introduction
11.6.4 Menohua Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.6.5 Menohua Recent Development
11.7 Tianyu shares
11.7.1 Tianyu shares Company Details
11.7.2 Tianyu shares Business Overview
11.7.3 Tianyu shares Small Molecule Chemical Drug CDMO Introduction
11.7.4 Tianyu shares Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.7.5 Tianyu shares Recent Development
11.8 Aoxiang Pharmaceutical
11.8.1 Aoxiang Pharmaceutical Company Details
11.8.2 Aoxiang Pharmaceutical Business Overview
11.8.3 Aoxiang Pharmaceutical Small Molecule Chemical Drug CDMO Introduction
11.8.4 Aoxiang Pharmaceutical Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.8.5 Aoxiang Pharmaceutical Recent Development
11.9 Hetero
11.9.1 Hetero Company Details
11.9.2 Hetero Business Overview
11.9.3 Hetero Small Molecule Chemical Drug CDMO Introduction
11.9.4 Hetero Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.9.5 Hetero Recent Development
11.10 CellMark
11.10.1 CellMark Company Details
11.10.2 CellMark Business Overview
11.10.3 CellMark Small Molecule Chemical Drug CDMO Introduction
11.10.4 CellMark Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.10.5 CellMark Recent Development
11.11 R&D Systems
11.11.1 R&D Systems Company Details
11.11.2 R&D Systems Business Overview
11.11.3 R&D Systems Small Molecule Chemical Drug CDMO Introduction
11.11.4 R&D Systems Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.11.5 R&D Systems Recent Development
11.12 Porton Pharmaceuticals
11.12.1 Porton Pharmaceuticals Company Details
11.12.2 Porton Pharmaceuticals Business Overview
11.12.3 Porton Pharmaceuticals Small Molecule Chemical Drug CDMO Introduction
11.12.4 Porton Pharmaceuticals Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.12.5 Porton Pharmaceuticals Recent Development
11.13 Kai Laiying
11.13.1 Kai Laiying Company Details
11.13.2 Kai Laiying Business Overview
11.13.3 Kai Laiying Small Molecule Chemical Drug CDMO Introduction
11.13.4 Kai Laiying Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.13.5 Kai Laiying Recent Development
11.14 Smart Life
11.14.1 Smart Life Company Details
11.14.2 Smart Life Business Overview
11.14.3 Smart Life Small Molecule Chemical Drug CDMO Introduction
11.14.4 Smart Life Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.14.5 Smart Life Recent Development
11.15 Notai Biotech
11.15.1 Notai Biotech Company Details
11.15.2 Notai Biotech Business Overview
11.15.3 Notai Biotech Small Molecule Chemical Drug CDMO Introduction
11.15.4 Notai Biotech Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.15.5 Notai Biotech Recent Development
11.16 Aurobindo Pharma
11.16.1 Aurobindo Pharma Company Details
11.16.2 Aurobindo Pharma Business Overview
11.16.3 Aurobindo Pharma Small Molecule Chemical Drug CDMO Introduction
11.16.4 Aurobindo Pharma Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.16.5 Aurobindo Pharma Recent Development
11.17 Lonza Group
11.17.1 Lonza Group Company Details
11.17.2 Lonza Group Business Overview
11.17.3 Lonza Group Small Molecule Chemical Drug CDMO Introduction
11.17.4 Lonza Group Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.17.5 Lonza Group Recent Development
11.18 Catalent Inc.
11.18.1 Catalent Inc. Company Details
11.18.2 Catalent Inc. Business Overview
11.18.3 Catalent Inc. Small Molecule Chemical Drug CDMO Introduction
11.18.4 Catalent Inc. Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.18.5 Catalent Inc. Recent Development
11.19 Recipharm AB
11.19.1 Recipharm AB Company Details
11.19.2 Recipharm AB Business Overview
11.19.3 Recipharm AB Small Molecule Chemical Drug CDMO Introduction
11.19.4 Recipharm AB Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.19.5 Recipharm AB Recent Development
11.20 Jubilant Pharmova Ltd
11.20.1 Jubilant Pharmova Ltd Company Details
11.20.2 Jubilant Pharmova Ltd Business Overview
11.20.3 Jubilant Pharmova Ltd Small Molecule Chemical Drug CDMO Introduction
11.20.4 Jubilant Pharmova Ltd Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.20.5 Jubilant Pharmova Ltd Recent Development
11.21 Patheon Inc. (Thermo Fisher Scientific Inc.)
11.21.1 Patheon Inc. (Thermo Fisher Scientific Inc.) Company Details
11.21.2 Patheon Inc. (Thermo Fisher Scientific Inc.) Business Overview
11.21.3 Patheon Inc. (Thermo Fisher Scientific Inc.) Small Molecule Chemical Drug CDMO Introduction
11.21.4 Patheon Inc. (Thermo Fisher Scientific Inc.) Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.21.5 Patheon Inc. (Thermo Fisher Scientific Inc.) Recent Development
11.22 Boehringer Ingelheim Group
11.22.1 Boehringer Ingelheim Group Company Details
11.22.2 Boehringer Ingelheim Group Business Overview
11.22.3 Boehringer Ingelheim Group Small Molecule Chemical Drug CDMO Introduction
11.22.4 Boehringer Ingelheim Group Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.22.5 Boehringer Ingelheim Group Recent Development
11.23 Pfizer CentreSource
11.23.1 Pfizer CentreSource Company Details
11.23.2 Pfizer CentreSource Business Overview
11.23.3 Pfizer CentreSource Small Molecule Chemical Drug CDMO Introduction
11.23.4 Pfizer CentreSource Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.23.5 Pfizer CentreSource Recent Development
11.24 Baxter International Inc.
11.24.1 Baxter International Inc. Company Details
11.24.2 Baxter International Inc. Business Overview
11.24.3 Baxter International Inc. Small Molecule Chemical Drug CDMO Introduction
11.24.4 Baxter International Inc. Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025)
11.24.5 Baxter International Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Small Molecule Chemical Drug CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Human Medicine
Table 3. Key Players of Veterinary Medicine
Table 4. Global Small Molecule Chemical Drug CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Small Molecule Chemical Drug CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Small Molecule Chemical Drug CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Small Molecule Chemical Drug CDMO Market Share by Region (2020-2025)
Table 8. Global Small Molecule Chemical Drug CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Small Molecule Chemical Drug CDMO Market Share by Region (2026-2031)
Table 10. Small Molecule Chemical Drug CDMO Market Trends
Table 11. Small Molecule Chemical Drug CDMO Market Drivers
Table 12. Small Molecule Chemical Drug CDMO Market Challenges
Table 13. Small Molecule Chemical Drug CDMO Market Restraints
Table 14. Global Small Molecule Chemical Drug CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Small Molecule Chemical Drug CDMO Market Share by Players (2020-2025)
Table 16. Global Top Small Molecule Chemical Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Chemical Drug CDMO as of 2024)
Table 17. Ranking of Global Top Small Molecule Chemical Drug CDMO Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Small Molecule Chemical Drug CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Small Molecule Chemical Drug CDMO, Headquarters and Area Served
Table 20. Global Key Players of Small Molecule Chemical Drug CDMO, Product and Application
Table 21. Global Key Players of Small Molecule Chemical Drug CDMO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Small Molecule Chemical Drug CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Small Molecule Chemical Drug CDMO Revenue Market Share by Type (2020-2025)
Table 25. Global Small Molecule Chemical Drug CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Small Molecule Chemical Drug CDMO Revenue Market Share by Type (2026-2031)
Table 27. Global Small Molecule Chemical Drug CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Small Molecule Chemical Drug CDMO Revenue Market Share by Application (2020-2025)
Table 29. Global Small Molecule Chemical Drug CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Small Molecule Chemical Drug CDMO Revenue Market Share by Application (2026-2031)
Table 31. North America Small Molecule Chemical Drug CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Small Molecule Chemical Drug CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Small Molecule Chemical Drug CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Small Molecule Chemical Drug CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Small Molecule Chemical Drug CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Small Molecule Chemical Drug CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Small Molecule Chemical Drug CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Small Molecule Chemical Drug CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Small Molecule Chemical Drug CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Small Molecule Chemical Drug CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Small Molecule Chemical Drug CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Small Molecule Chemical Drug CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Small Molecule Chemical Drug CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Small Molecule Chemical Drug CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Small Molecule Chemical Drug CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 46. Haixiang Pharmaceutical Company Details
Table 47. Haixiang Pharmaceutical Business Overview
Table 48. Haixiang Pharmaceutical Small Molecule Chemical Drug CDMO Product
Table 49. Haixiang Pharmaceutical Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 50. Haixiang Pharmaceutical Recent Development
Table 51. Innovent Biologics Company Details
Table 52. Innovent Biologics Business Overview
Table 53. Innovent Biologics Small Molecule Chemical Drug CDMO Product
Table 54. Innovent Biologics Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 55. Innovent Biologics Recent Development
Table 56. Betta Pharmaceuticals Company Details
Table 57. Betta Pharmaceuticals Business Overview
Table 58. Betta Pharmaceuticals Small Molecule Chemical Drug CDMO Product
Table 59. Betta Pharmaceuticals Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 60. Betta Pharmaceuticals Recent Development
Table 61. Jiuzhou Pharmaceutical Company Details
Table 62. Jiuzhou Pharmaceutical Business Overview
Table 63. Jiuzhou Pharmaceutical Small Molecule Chemical Drug CDMO Product
Table 64. Jiuzhou Pharmaceutical Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 65. Jiuzhou Pharmaceutical Recent Development
Table 66. Puluo Pharmaceutical Company Details
Table 67. Puluo Pharmaceutical Business Overview
Table 68. Puluo Pharmaceutical Small Molecule Chemical Drug CDMO Product
Table 69. Puluo Pharmaceutical Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 70. Puluo Pharmaceutical Recent Development
Table 71. Menohua Company Details
Table 72. Menohua Business Overview
Table 73. Menohua Small Molecule Chemical Drug CDMO Product
Table 74. Menohua Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 75. Menohua Recent Development
Table 76. Tianyu shares Company Details
Table 77. Tianyu shares Business Overview
Table 78. Tianyu shares Small Molecule Chemical Drug CDMO Product
Table 79. Tianyu shares Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 80. Tianyu shares Recent Development
Table 81. Aoxiang Pharmaceutical Company Details
Table 82. Aoxiang Pharmaceutical Business Overview
Table 83. Aoxiang Pharmaceutical Small Molecule Chemical Drug CDMO Product
Table 84. Aoxiang Pharmaceutical Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 85. Aoxiang Pharmaceutical Recent Development
Table 86. Hetero Company Details
Table 87. Hetero Business Overview
Table 88. Hetero Small Molecule Chemical Drug CDMO Product
Table 89. Hetero Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 90. Hetero Recent Development
Table 91. CellMark Company Details
Table 92. CellMark Business Overview
Table 93. CellMark Small Molecule Chemical Drug CDMO Product
Table 94. CellMark Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 95. CellMark Recent Development
Table 96. R&D Systems Company Details
Table 97. R&D Systems Business Overview
Table 98. R&D Systems Small Molecule Chemical Drug CDMO Product
Table 99. R&D Systems Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 100. R&D Systems Recent Development
Table 101. Porton Pharmaceuticals Company Details
Table 102. Porton Pharmaceuticals Business Overview
Table 103. Porton Pharmaceuticals Small Molecule Chemical Drug CDMO Product
Table 104. Porton Pharmaceuticals Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 105. Porton Pharmaceuticals Recent Development
Table 106. Kai Laiying Company Details
Table 107. Kai Laiying Business Overview
Table 108. Kai Laiying Small Molecule Chemical Drug CDMO Product
Table 109. Kai Laiying Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 110. Kai Laiying Recent Development
Table 111. Smart Life Company Details
Table 112. Smart Life Business Overview
Table 113. Smart Life Small Molecule Chemical Drug CDMO Product
Table 114. Smart Life Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 115. Smart Life Recent Development
Table 116. Notai Biotech Company Details
Table 117. Notai Biotech Business Overview
Table 118. Notai Biotech Small Molecule Chemical Drug CDMO Product
Table 119. Notai Biotech Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 120. Notai Biotech Recent Development
Table 121. Aurobindo Pharma Company Details
Table 122. Aurobindo Pharma Business Overview
Table 123. Aurobindo Pharma Small Molecule Chemical Drug CDMO Product
Table 124. Aurobindo Pharma Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 125. Aurobindo Pharma Recent Development
Table 126. Lonza Group Company Details
Table 127. Lonza Group Business Overview
Table 128. Lonza Group Small Molecule Chemical Drug CDMO Product
Table 129. Lonza Group Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 130. Lonza Group Recent Development
Table 131. Catalent Inc. Company Details
Table 132. Catalent Inc. Business Overview
Table 133. Catalent Inc. Small Molecule Chemical Drug CDMO Product
Table 134. Catalent Inc. Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 135. Catalent Inc. Recent Development
Table 136. Recipharm AB Company Details
Table 137. Recipharm AB Business Overview
Table 138. Recipharm AB Small Molecule Chemical Drug CDMO Product
Table 139. Recipharm AB Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 140. Recipharm AB Recent Development
Table 141. Jubilant Pharmova Ltd Company Details
Table 142. Jubilant Pharmova Ltd Business Overview
Table 143. Jubilant Pharmova Ltd Small Molecule Chemical Drug CDMO Product
Table 144. Jubilant Pharmova Ltd Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 145. Jubilant Pharmova Ltd Recent Development
Table 146. Patheon Inc. (Thermo Fisher Scientific Inc.) Company Details
Table 147. Patheon Inc. (Thermo Fisher Scientific Inc.) Business Overview
Table 148. Patheon Inc. (Thermo Fisher Scientific Inc.) Small Molecule Chemical Drug CDMO Product
Table 149. Patheon Inc. (Thermo Fisher Scientific Inc.) Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 150. Patheon Inc. (Thermo Fisher Scientific Inc.) Recent Development
Table 151. Boehringer Ingelheim Group Company Details
Table 152. Boehringer Ingelheim Group Business Overview
Table 153. Boehringer Ingelheim Group Small Molecule Chemical Drug CDMO Product
Table 154. Boehringer Ingelheim Group Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 155. Boehringer Ingelheim Group Recent Development
Table 156. Pfizer CentreSource Company Details
Table 157. Pfizer CentreSource Business Overview
Table 158. Pfizer CentreSource Small Molecule Chemical Drug CDMO Product
Table 159. Pfizer CentreSource Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 160. Pfizer CentreSource Recent Development
Table 161. Baxter International Inc. Company Details
Table 162. Baxter International Inc. Business Overview
Table 163. Baxter International Inc. Small Molecule Chemical Drug CDMO Product
Table 164. Baxter International Inc. Revenue in Small Molecule Chemical Drug CDMO Business (2020-2025) & (US$ Million)
Table 165. Baxter International Inc. Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
Table 169. Authors List of This Report
List of Figures
Figure 1. Small Molecule Chemical Drug CDMO Picture
Figure 2. Global Small Molecule Chemical Drug CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Small Molecule Chemical Drug CDMO Market Share by Type: 2024 VS 2031
Figure 4. Human Medicine Features
Figure 5. Veterinary Medicine Features
Figure 6. Global Small Molecule Chemical Drug CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Small Molecule Chemical Drug CDMO Market Share by Application: 2024 VS 2031
Figure 8. Clinical Stage Projects Case Studies
Figure 9. Commercialization Stage Projects Case Studies
Figure 10. Small Molecule Chemical Drug CDMO Report Years Considered
Figure 11. Global Small Molecule Chemical Drug CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Small Molecule Chemical Drug CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Small Molecule Chemical Drug CDMO Market Share by Region: 2024 VS 2031
Figure 14. Global Small Molecule Chemical Drug CDMO Market Share by Players in 2024
Figure 15. Global Top Small Molecule Chemical Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Chemical Drug CDMO as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Small Molecule Chemical Drug CDMO Revenue in 2024
Figure 17. North America Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Small Molecule Chemical Drug CDMO Market Share by Country (2020-2031)
Figure 19. United States Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Small Molecule Chemical Drug CDMO Market Share by Country (2020-2031)
Figure 23. Germany Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Small Molecule Chemical Drug CDMO Market Share by Region (2020-2031)
Figure 31. China Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Small Molecule Chemical Drug CDMO Market Share by Country (2020-2031)
Figure 39. Mexico Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Small Molecule Chemical Drug CDMO Market Share by Country (2020-2031)
Figure 43. Turkey Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Small Molecule Chemical Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Haixiang Pharmaceutical Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 47. Innovent Biologics Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 48. Betta Pharmaceuticals Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 49. Jiuzhou Pharmaceutical Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 50. Puluo Pharmaceutical Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 51. Menohua Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 52. Tianyu shares Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 53. Aoxiang Pharmaceutical Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 54. Hetero Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 55. CellMark Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 56. R&D Systems Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 57. Porton Pharmaceuticals Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 58. Kai Laiying Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 59. Smart Life Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 60. Notai Biotech Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 61. Aurobindo Pharma Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 62. Lonza Group Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 63. Catalent Inc. Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 64. Recipharm AB Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 65. Jubilant Pharmova Ltd Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 66. Patheon Inc. (Thermo Fisher Scientific Inc.) Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 67. Boehringer Ingelheim Group Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 68. Pfizer CentreSource Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 69. Baxter International Inc. Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
